Zusammenfassung
Der Mobus Osler (Synonyme: hereditäre hämorrhagische Teleangiektasie [HHT], Morbus Rendu-Osler-Weber) ist eine Multisystemerkrankung und gehört zur Gruppe der vaskulären hämorrhagischen Erkrankungen. Bei der autosomal dominanten Erkrankung, die zu den häufigsten Phakomatosen zählt, kann je nach Gendefekt zwischen verschiedenen Formen, die zu einer Störung der Blutgefäßbildung führen, unterschieden werden. Neben der genetischen Diagnostik und der klinischen Untersuchung sind bildgebende Verfahren entscheidend für die Diagnose. Klinisch stehen die Epistaxis, mukokutane Teleangiektasien und viszerale arteriovenöse Malformationen (AVM) v. a. in Lunge, Leber und Hirn sowie die Folgen dieser Gefäßpathologien wie z. B. intrakranielle Abszesse und Hirninfarkte im Vordergrund. Sie können mit der modernen Bildgebung magnetresonanz- und computertomographisch nachgewiesen werden. Pulmonale AVM können häufig computertomographisch auch ohne Kontrastmittelgabe diagnostiziert werden, wohingegen die anderen viszeralen Manifestationen einschließlich einer etwaigen zentralnervösen Beteiligung in der Regel eine Kontrastmittelgabe in der MRT oder CT erforderlich machen. Kenntnisse über die mögliche Organmanifestation, resultierende Komplikationen und die typischen radiologischen Befunde sind entscheidend für die adäquate Behandlung der betroffenen Patienten. Die interventionelle Radiologie/Neuroradiologie spielt auch zunehmend eine wichtige Rolle bei der Behandlung von HHT-Patienten.
Abstract
Osler’s disease, also known as hereditary hemorrhagic telangiectasia (HHT) and Osler-Weber-Rendu syndrome, is an autosomal dominant disorder leading to abnormal blood vessel formation in the skin, mucous membranes and often in organs, such as the lungs, liver and brain (arteriovenous malformations AVM). Various types are known. Patients may present with epistaxis. Teleangiectasia can be identified by visual inspection during physical examination of the skin or oral cavity or by endoscopy. Diagnosis is made after clinical examination and genetic testing based on the Curacao criteria. Modern imaging modalities, such as computed tomography (CT) or magnetic resonance imaging (MRI) have become more important as they can depict the AVMs. Pulmonary AVMs can be depicted in CT imaging even without the use of a contrast agent while other locations including the central nervous system (CNS) usually require administration of contrast agents. Knowledge of possible clinical manifestations in various organs, possible complications and typical radiological presentation is mandatory to enable adequate therapy of these patients. Interventional procedures are becoming increasingly more important in the treatment of HHT patients.
Literatur
Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95(4):422–427
Buscarini E, Buscarini L, Danesino C et al (1997) Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 26:111–118
Carette MF, Brugieres P, Khalil A (2007) Hyperintense basal ganglia on T1-weighted images in Rendu-Osler-Weber disease. Presse Med 36:883–884
Carette MF, Nedelcu C, Tassart M et al (2009) Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 32(4):745–757. doi:10.1007/s00270-008-9344-2
Cottin V, Chinet T, Lavolé A et al (2007) Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 86:1–17
Easey AJ, Wallace GM, Hughes JM et al (2003) Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life. J Neurol Neurosurg Psychiatry 74:743–748
Fulbright RK, Chaloupka JC, Putman CM et al (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19:477–484
Garcia-Monaco R, Taylor W, Rodesch G et al (1995) Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 37:60–64
Graf CJ, Perret GE, Torner JC (1983) Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58:331–337
Ianora AA, Memeo M, Sabba C et al (2004) Hereditary hemorrhagic telangiectasia: multi – detector row helical CT assessment of hepatic involvement. Radiology 230:250–259
Jaskolka J, Wu L, Chan RP, Faughnan ME (2003) Imaging of hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 183:307–314
Khalil A, Farres MT, Mangiapan G et al (2000) Pulmonary arteriovenous malformations. Chest 117:1399–1403
Kim TK, Choi BI, Han JK et al (1998) Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: twophase spiral CT findings. Radiology 208:597–603
Krings T, Chng SM, Ozanne A et al (2005) Hereditary haemorrhagic telangiectasia in children. endovascular treatment of neurovascular malformations results in 31 patients interventional. Neuroradiology 11:13–23
Lesca G, Olivieri C, Burnichon N et al (2007) Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 9:14–22
Maarouf M, Runge M, Kocher M et al (2004) Radiosurgery for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia. Neurology 63:367–369
Maher CO, Piepgras DG, Brown RD Jr et al (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32:877–882
Memeo M, Stabile Ianora AA, Scardapane A et al (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 29:211–220
Nanthakumar K, Graham AT, Robinson TI et al (2001) Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 141:243–246
Oliver JH 3rd, Baron RL (1996) Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 201:1–14
Remy-Jardin M, Dumont P, Brillet PY et al (2006) Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2–21-year follow-up. Radiology 239:576–585
Remy J, Remy-Jardin M, Wattinne L, Deffontaines C (1992) Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 182:809–816
Siddiki H, Doherty MG, Fletcher JG et al (2008) Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. Radiographics 28(1):171–184. doi:10.1148/rg.281075037
Weber MA, Ahlhelm F, Essig M et al (2007) Treatment options for arteriovenous malformations. Radiologe 47(10):893–899
Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76(8):495–501
White RI Jr, Lynch-Nyhan A, Terry P et al (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169:663–669
White RI Jr, Pollack JS, Wirth JA (1996) Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 7:787–804
Yu JS, Kim KW, Sung KB et al (1997) Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203:737–742
Einhaltung ethischer Richtlinien
Interessenkonflikt. F. Ahlhelm, J. Lieb, G. Schneider, U. Müller, S. Ulmer geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahlhelm, F., Lieb, J., Schneider, G. et al. Morbus Osler. Radiologe 53, 1084–1090 (2013). https://doi.org/10.1007/s00117-013-2552-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-013-2552-z
Schlüsselwörter
- Phakomatosen
- Hereditäre hämorrhagische Teleangiektasie
- AV-Shunts
- Moderne Bildgebung
- Interventionelle Radiologie